JW Lifescience Corporation (KRX: 234080)

JW Lifescience Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	221,321	206,860	188,931	169,817	183,521	170,221
Other Revenue	-0	-	-0	-0	-	-
Revenue	221,321	206,860	188,931	169,817	183,521	170,221
Revenue Growth (YoY)	8.78%	9.49%	11.26%	-7.47%	7.81%	9.66%
Cost of Revenue	164,756	154,507	140,972	120,788	124,243	121,799
Gross Profit	56,564	52,353	47,959	49,029	59,278	48,422
Selling, General & Admin	16,447	15,100	13,358	12,908	13,180	13,833
Research & Development	4,779	5,161	5,737	6,242	5,195	3,583
Other Operating Expenses	265.78	161.56	159.04	162.39	199.85	218.51
Operating Expenses	22,313	21,491	20,870	20,612	19,827	18,673
Operating Income	34,252	30,862	27,089	28,417	39,451	29,749
Interest Expense	-2,172	-2,693	-3,092	-1,281	-2,609	-1,726
Interest & Investment Income	1,346	1,130	1,087	130.36	1,427	34.3
Earnings From Equity Investments	2,853	6,489	-4,921	-4,780	-7,129	0.14
Currency Exchange Gain (Loss)	2,471	-651.41	329.73	-149.04	-150.86	-118.6
Other Non Operating Income (Expenses)	-3,670	-1,251	296.71	-3,772	-8,197	373.21
EBT Excluding Unusual Items	35,079	33,886	20,789	18,565	22,791	28,312
Gain (Loss) on Sale of Assets	4.9	-	-	1.71	-4.14	18.96
Asset Writedown	-165.33	-166.58	-7.42	-279.65	-46.75	-
Other Unusual Items	-	-10.72	-	-	-	-
Pretax Income	34,966	33,708	20,782	18,287	22,740	28,331
Income Tax Expense	6,149	5,564	5,821	5,373	5,440	6,393
Net Income	28,817	28,144	14,961	12,914	17,300	21,938
Net Income to Common	28,817	28,144	14,961	12,914	17,300	21,938
Net Income Growth	28.34%	88.11%	15.86%	-25.36%	-21.14%	38.67%
Shares Outstanding (Basic)	15	15	15	16	16	16
Shares Outstanding (Diluted)	15	15	15	16	16	16
Shares Change (YoY)	-	-	-0.61%	-1.61%	-	-
EPS (Basic)	1860.99	1817.55	966.21	828.84	1092.55	1385.48
EPS (Diluted)	1860.99	1817.55	966.00	828.84	1092.55	1385.48
EPS Growth	28.34%	88.15%	16.55%	-24.14%	-21.14%	38.67%
Free Cash Flow	47,764	29,421	6,049	11,189	30,824	16,183
Free Cash Flow Per Share	3084.61	1900.03	390.67	718.14	1946.62	1022.02
Dividend Per Share	500.000	500.000	500.000	500.000	500.000	500.000
Gross Margin	25.56%	25.31%	25.38%	28.87%	32.30%	28.45%
Operating Margin	15.48%	14.92%	14.34%	16.73%	21.50%	17.48%
Profit Margin	13.02%	13.61%	7.92%	7.60%	9.43%	12.89%
Free Cash Flow Margin	21.58%	14.22%	3.20%	6.59%	16.80%	9.51%
EBITDA	50,002	46,393	42,045	41,661	51,697	41,375
EBITDA Margin	22.59%	22.43%	22.25%	24.53%	28.17%	24.31%
D&A For EBITDA	15,750	15,531	14,956	13,245	12,246	11,626
EBIT	34,252	30,862	27,089	28,417	39,451	29,749
EBIT Margin	15.48%	14.92%	14.34%	16.73%	21.50%	17.48%
Effective Tax Rate	17.59%	16.51%	28.01%	29.38%	23.92%	22.56%
Advertising Expenses	-	1,731	1,605	1,666	1,039	1,750

Source: S&P Capital IQ. Standard template. Financial Sources.